Company registration number 03873649 (England and Wales)
ALLINGTON HEALTHCARE LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
ALLINGTON HEALTHCARE LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
ALLINGTON HEALTHCARE LIMITED
BALANCE SHEET
AS AT
31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
5
403,860
423,019
Current assets
Stocks
1,065
1,015
Debtors
6
79,798
31,537
Cash at bank and in hand
50,205
4,365
131,068
36,917
Creditors: amounts falling due within one year
7
(103,994)
(101,774)
Net current assets/(liabilities)
27,074
(64,857)
Total assets less current liabilities
430,934
358,162
Provisions for liabilities
(1,287)
(1,495)
Net assets
429,647
356,667
Capital and reserves
Called up share capital
400
400
Profit and loss reserves
429,247
356,267
Total equity
429,647
356,667

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 8 November 2024 and are signed on its behalf by:
J Deane
A McLean
Director
Director
Company Registration No. 03873649
ALLINGTON HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

Allington Healthcare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 5 Yeomans Court, Ware Road, Hertford, Hertfordshire, United Kingdom, SG13 7HJ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover comprises the value of fees receivable exclusive of Value Added Tax and is recognised when the service has been provided. The whole of the turnover is attributable to fees receivable from the operation of care homes.

1.4
Intangible fixed assets - goodwill

Amortisation is charged to write off the cost of the intangible assets less their residual values over their estimated useful lives on a straight line basis. The intangible assets are written off over the following useful economic lives:

Goodwill - 10 year

 

If there are indicators of a significant movement in the useful life or residual value of the asset, amortisation is revised prospectively to reflect this.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
Straight line over 40 years
Fixtures and fittings
20% on a straight line basis
Computers
33% on a straight line basis

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

ALLINGTON HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.8
Financial instruments
Trade and other debtors

Trade and other debtors are measured at transaction price less any impairment unless the arrangements constitutes a financing transaction in which case the transaction is measured at the present value of the future receipts discounted at the prevailing market rate of interest. Loans are initially measured at fair value and are subsequently measured at amortised cost using the effective interest method.

Trade and other creditors

Trade and other creditors are measured at their transaction price unless the arrangement constitutes a financing transaction in which case the transaction is measured at present value of future payments discounted at prevailing market rate of interest. Other financial liabilities are initially measured at fair value net of their transaction costs. They are subsequently measured at amortised cost using the effective interest method.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

ALLINGTON HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 4 -
1.11
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

 

The directors consider that there are no significant judgements and estimates in the preparation of these accounts.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
44
38
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2023 and 31 March 2024
13,000
Amortisation and impairment
At 1 April 2023 and 31 March 2024
13,000
Carrying amount
At 31 March 2024
-
0
At 31 March 2023
-
0
ALLINGTON HEALTHCARE LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2023 and 31 March 2024
751,457
34,125
785,582
Depreciation and impairment
At 1 April 2023
338,340
24,223
362,563
Depreciation charged in the year
16,239
2,920
19,159
At 31 March 2024
354,579
27,143
381,722
Carrying amount
At 31 March 2024
396,878
6,982
403,860
At 31 March 2023
413,117
9,902
423,019
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
70,547
20,402
Corporation tax recoverable
-
0
2,935
Other debtors
9,251
8,200
79,798
31,537
7
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
-
0
16,065
Trade creditors
12,835
14,537
Corporation tax
28,035
-
0
Other taxation and social security
5,994
6,502
Other creditors
57,130
64,670
103,994
101,774
8
Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. Contributions totalling £1,832 (2023: £1,855) were payable to the fund at the balance sheet date.

2024-03-312023-04-01false08 November 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityJ DeaneA McLeanB A McLeanK WalshJ Deanefalsefalse038736492023-04-012024-03-31038736492024-03-31038736492023-03-3103873649core:LandBuildings2024-03-3103873649core:OtherPropertyPlantEquipment2024-03-3103873649core:LandBuildings2023-03-3103873649core:OtherPropertyPlantEquipment2023-03-3103873649core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3103873649core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3103873649core:CurrentFinancialInstruments2024-03-3103873649core:CurrentFinancialInstruments2023-03-3103873649core:ShareCapital2024-03-3103873649core:ShareCapital2023-03-3103873649core:RetainedEarningsAccumulatedLosses2024-03-3103873649core:RetainedEarningsAccumulatedLosses2023-03-3103873649bus:CompanySecretaryDirector12023-04-012024-03-3103873649bus:Director12023-04-012024-03-3103873649core:Goodwill2023-04-012024-03-3103873649core:LandBuildingscore:OwnedOrFreeholdAssets2023-04-012024-03-3103873649core:FurnitureFittings2023-04-012024-03-3103873649core:ComputerEquipment2023-04-012024-03-31038736492022-04-012023-03-3103873649core:NetGoodwill2023-03-3103873649core:NetGoodwill2024-03-3103873649core:NetGoodwill2023-03-3103873649core:LandBuildings2023-03-3103873649core:OtherPropertyPlantEquipment2023-03-31038736492023-03-3103873649core:LandBuildings2023-04-012024-03-3103873649core:OtherPropertyPlantEquipment2023-04-012024-03-3103873649core:WithinOneYear2024-03-3103873649core:WithinOneYear2023-03-3103873649bus:PrivateLimitedCompanyLtd2023-04-012024-03-3103873649bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3103873649bus:FRS1022023-04-012024-03-3103873649bus:AuditExemptWithAccountantsReport2023-04-012024-03-3103873649bus:Director22023-04-012024-03-3103873649bus:Director32023-04-012024-03-3103873649bus:Director42023-04-012024-03-3103873649bus:CompanySecretary12023-04-012024-03-3103873649bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP